Close Menu

NEW YORK (GenomeWeb) – Applied BioCode said today that it has received US Food and Drug Administration 510(k) clearance for the BioCode Gastrointestinal Pathogen Panel (GPP) with the BioCode MDx-3000 molecular system.

The BioCode GPP tests for 17 of the most common bacteria, viruses, and parasites that cause infectious diarrhea. It runs on the BioCode MDx-3000, which automates PCR amplification, hybridization/target capture, and detection, and can process up to 94 samples in about 3.5 hours or generate up to 3,196 results in an eight-hour shift, Applied BioCode said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.